A 37-year-old lady with infective endocarditis of the mitral valve presented in congestive cardiac failure. However, the clinical scenario became complicated when she was also found to have antiphospholipid antibody syndrome. Meticulous optimization and timely surgical intervention by a multidisciplinary team helped mitigate this not so common situation and lead to successful outcome.
RodziewiczMD’CruzDP. An update on the management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis [Internet]2020; 12: 1759720X20910855.
2.
EviatarTNiznikSElkayamO, et al.Heart valve surgery in antiphospholipid syndrome patients-morbidity and mortality. Life (Basel) [Internet]2023; 13: 891.
3.
BeliznaC. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. Autoimmun Rev [Internet]. 2015; 14: 358–362.
4.
KoniariISiminelakisSNBaikoussisNG, et al.Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. J Cardiothorac Surg [Internet]2010[cited 2023 Jul 13]; 5: 101. http://www.cardiothoracicsurgery.org/content/5/1/101
5.
AndoYNaganoKMoritaS, et al.Anesthetic management for a patient with anti-phospholipid antigen syndrome. Masui2009; 58: 1007–1009.
6.
GorkiHMalinovskiVStanbridgeRD. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg2008; 33: 168–181. Epub 2007 Dec 21. PMID: 18082413.
7.
ColliAMestresCAEspinosaG, et al.Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg [Internet]2010; 37: 154–158.
8.
HeyeTReemtsenBGreitenL. The MITRIS RESILIA mitral valve is a safe and effective option for mitral valve replacement in young patients requiring mitral valve replacement. Cardiol Young [Internet]2022; 33: 1–3.
